相关实验视频
Updated: Jul 12, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
在重症COPD患者的支气管镜肺体积减小方面取得的最新进展
Rein Posthuma1,2,3, Anouk W Vaes1, Martijn A Spruit1,2,3
1Department of Research and Development, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn.
支气管镜肺体积减小 (BLVR) 对慢性阻塞性肺病 (COPD) 患有晚期肺瘤的患者提供了显著的益处. 最近的进展表明,即使在标准标准之外的患者中,结果也得到了改善,这表明潜在的生存益处.
科学领域:
- 肺部医学 肺部医学
- 干预性肺病学 干预性肺病学
背景情况:
- 慢性阻塞性肺病 (COPD) 与晚期肺气导致严重的呼吸困难和肺部膨胀.
- 支气管镜式肺体积减小 (BLVR) 是针对特定COPD表型的已知治疗方法.
研究的目的:
- 审查COPD的支气管镜肺体积减小 (BLVR) 的最新进展.
- 突出患者选择标准和目标叶的识别,以获得最佳的BLVR结果.
- 讨论BLVR的疗效,长期结果和生存益处.
主要方法:
- 对BLVR最近的临床研究和分析的审查.
- 响应BLVR的患者表型的特征.
- 对响应者与非响应者的目标叶特征 (肺瘤,气, perfusion) 的分析.
主要成果:
- BLVR改善了COPD患者的肺功能,运动能力和生活质量.
- 患有中度高通胀,慢性高膜衰竭或低扩散能力的患者可能受益于BLVR.
- 研究表明,在接受BLVR治疗的患者中,持续的长期结果和潜在的生存益处.
- 随着时间的推移,疾病的进展可能会导致BLVR效应的下降.
结论:
- BLVR是指导方针推的治疗方法,用于专门中心的COPD患者.
- 最近的研究扩大了BLVR的标准,证明了对更广泛的患者群体的好处.
- BLVR的长期疗效是持续的,尽管疾病的进展可能会随着时间的推移影响结果.
更多相关视频
04:10Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
Published on: July 19, 2024
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...